Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/24 20:00 | 5/9/24 | LGND | Health | Drug | Pharmaceutical Preparations | Gray Nancy Ryan | FL | D | 1 | S | -78 | 83.20 | 0 | -1 | 6 | D | ||||||||||||||||
5/17/24 19:59 | 5/15/24 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | 2 | S.dm | -1,159 | 86.29 | 0 | -13 | 30 | D | |||||||||||||||
5/15/24 19:34 | 5/13/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | 1 | S.m | -1,496 | 84.99 | 0 | -18 | 86 | D | |||||||||||||||
5/13/24 17:32 | 5/9/24 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | GC, | 2 | S.d | -851 | 82.66 | 0 | -10 | 22 | D | |||||||||||||||
3/7/24 13:27 | 3/5/24 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | 2 | S.d | -635 | 76.48 | 0 | -8 | 29 | D | ||||||||||||||||
5/18/23 17:18 | 5/16/23 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | 2 | S.d | -834 | 76.83 | 0 | -11 | 42 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |